Clearstead Trust’s Core Laboratories CLB Stock Holding History

Clearstead Trust’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-200	Closed	-$9K	–	182
2019 Q3	$9K	Hold	200	–	–	0.01%	165
2019 Q2	$10K	Hold	200	–	–	0.01%	161
2019 Q1	$14K	Hold	200	–	–	0.01%	159
2018 Q4	$12K	Hold	200	–	–	0.01%	181
2018 Q3	$23K	Hold	200	–	–	0.02%	149
2018 Q2	$25K	Buy	+200	New	+$24.3K	0.02%	151
2018 Q1	–	Sell	-200	Closed	-$22K	–	133
2017 Q4	$22K	Hold	200	–	–	0.02%	167
2017 Q3	$20K	Hold	200	–	–	0.01%	183
2017 Q2	$20K	Buy	+200	New	+$21.6K	0.02%	196

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Clearstead Trust's CLB Position: Q4 2019 in Review

Clearstead Trust sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 200 shares — an estimated $9K sold.

Clearstead Trust first reported a position in CLB in Q2 2017 and held it in 9 quarters. The position peaked at $25K in Q2 2018. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

Clearstead Trust reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
Clearstead Trust sold 200 Core Laboratories shares in Q4 2019, an estimated $9K.
Clearstead Trust first reported a position in Core Laboratories in Q2 2017 and held it in 9 quarters.
Clearstead Trust's Core Laboratories position peaked at $25K in Q2 2018.
283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on Clearstead Trust's 13F filing for Q4 2019, filed 3 Feb 2020.